Navigating paediatric virology through the COVID‑19 era
IN Mammas, SB Drysdale… - International …, 2023 - spandidos-publications.com
The present review article presents the key messages of the 8th Workshop on Paediatric
Virology organised virtually by the Institute of Paediatric Virology based on the island of …
Virology organised virtually by the Institute of Paediatric Virology based on the island of …
Optimizing ganciclovir and valganciclovir dosing regimens in pediatric patients with cytomegalovirus infection: a spotlight on therapeutic drug monitoring
QY Li, J van den Anker, YE Wu, GX Hao… - Expert review of clinical …, 2023 - Taylor & Francis
Introduction Infants and immunocompromised children with cytomegalovirus (CMV) infection
have significant morbidity and mortality. Ganciclovir (GCV) and its oral prodrug …
have significant morbidity and mortality. Ganciclovir (GCV) and its oral prodrug …
Prevalence of cytomegalovirus antiviral drug resistance in transplant recipients
SB Kleiboeker - Antiviral Research, 2023 - Elsevier
Cytomegalovirus (CMV) is a significant human pathogen, especially for
immunocompromised patients, often treated with one or more antiviral drugs. Although the …
immunocompromised patients, often treated with one or more antiviral drugs. Although the …
三级淋巴结构在器官移植排斥反应中的现状与展望
杨麒臻， 王英， 陈乾， 牛玉林 - 实用临床医药杂志 - jcmp.yzu.edu.cn
器官移植后, 移植物的排斥反应是最常见的并发症之一, 无论病因如何都会对移植物产生不良
损害. 三级淋巴结构(TLS) 于病理情况下非淋巴组织内发生. 针对调节移植物排斥反应的机制 …
损害. 三级淋巴结构(TLS) 于病理情况下非淋巴组织内发生. 针对调节移植物排斥反应的机制 …
Cytomegalovirus Prophylaxis With Letermovir in Pediatric, Adolescent, and Young-Adult Patients Undergoing Hematopoietic Stem-Cell Transplant.
M Dietz, R Chakravarthy, L Rogozinski… - Journal of …, 2024 - search.ebscohost.com
BACKGROUND: Cytomegalovirus (CMV) reactivation occurs in up to 70% of CMV-
seropositive patients undergoing allogeneic hematopoietic stem-cell transplantation (HSCT) …
seropositive patients undergoing allogeneic hematopoietic stem-cell transplantation (HSCT) …